Laith Alzweri, MBBS

Laith Alzweri practices at John Sealy Hospital in Galveston, Texas, part of The University of Texas System.

Laith Alzweri's NPI, 1285173690, was assigned on February 17, 2017. Laith Alzweri graduated from Jordan University of Science and Technology FOM in 2006. Laith Alzweri's Texas license number on file is 46857.

Laith Alzweri's primary practice is John Sealy Hospital, at 301 University Boulevard, Galveston, TX 77555 in Galveston County. The practice phone is (409) 772-1011.

Laith Alzweri's primary practice is John Sealy Hospital in Galveston, Texas, part of The University of Texas System. Laith Alzweri is also affiliated with The University of Texas MD Anderson Cancer Center. The medical group on file is UTMB Faculty Group Practice. Dmand AI also links Laith Alzweri to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Laith Alzweri practices, 3 sites in all. Vendor and product names are available with a free account.

Urology is Laith Alzweri's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dmand AI has Laith Alzweri's licenses on file in 3 states: Texas, Virginia and Louisiana.

Dmand AI lists enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease, testicular dysfunction and urinary endoscopy among the conditions Laith Alzweri treats.

CMS data shows 624 Medicare services from Laith Alzweri across 11 procedure codes in 2024, for 267 Medicare patients. Medicare paid $52,587 for them.

CMS counts 267 Medicare patients who saw Laith Alzweri in 2024. The largest group is 65 to 74, with 123 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.29, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Laith Alzweri's median patient age at 71, with 7% women.

In 2024, Laith Alzweri wrote 818 Medicare Part D claims for 301 patients. 93% of them were for generic drugs. CMS names the drug for 746 of them, across 14 drugs with 11 or more claims each, at $23,338 in total drug cost. In 2023, CMS named 459 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Laith Alzweri for performance year 2024, reported as part of a group. Laith Alzweri accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 26 procedures of prostate resection by Laith Alzweri, more than 88% of the clinicians it reports for that procedure.

Dmand AI links 30 papers to Laith Alzweri, published from 2015 to 2024. 2018 was the busiest year, with 6. The most frequent topics are Testosterone, Erectile Dysfunction and Sexual Dysfunction, Physiological. Laith Alzweri has published most often in Int J Impot Res. Laith Alzweri's most frequent co-authors are Faysal Anas Yafi, MD, Steven E. Canfield, MD and Arthur Louis Burnett, MD.

CMS Open Payments shows 93 general payments to Laith Alzweri from 10 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 52% of the total. Coloplast Corp paid the most, $5,603.

Laith Alzweri graduated from Jordan University of Science and Technology FOM in 2006.

Laith Alzweri is in network with 22 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.